| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/04/2002 | WO2002014317A3 Substituted pyrazoles |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2001078779A3 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | WO2001046176A3 Non peptide tachykinin receptor antagonists |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086906 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics |
| 07/04/2002 | US20020086882 Regulates immune and inflammatory responses by binding to alpha 4 integrin, also know as Very Late Antigen; antiinflammatory agent |
| 07/04/2002 | US20020086878 Monomolecular dispersions of various medicaments prepared for transmucosal delivery; treatment of respiratory illness such as cold and/or allergy |
| 07/04/2002 | US20020086864 Administering optically pure (S,S) enantiomer of reboxetine |
| 07/04/2002 | US20020086859 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 07/04/2002 | US20020086854 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 07/04/2002 | US20020086852 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 07/04/2002 | US20020086850 Antiinflammatory agents |
| 07/04/2002 | US20020086838 Such as antibodies, proteins, drugs such as spironolactone, imidapril, an angiotensin converting enzyme inhibitor, captopril, enalapril, defibrotide, and angiotensin II receptor antagonist |
| 07/04/2002 | US20020086836 Cftr gene regulator |
| 07/04/2002 | US20020086413 LktA deletion mutant of P. haemolytica |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086068 Herbal composition of blend of active components prepared from murrya koenigii and piper betle useful for blocking of 5 lipoxygenase activity leading to the inhibition of leukotriene synthesis, suppression of interleukin-4 production, and enhancement of gamma interferon release |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020085978 Containing a propellant, a cosolvent, and a radical quencher. |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10063435A1 Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Chinazolinderviate, medicaments containing these compounds, their use and process for their preparation |
| 07/04/2002 | DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | CA2436739A1 Combination agent |
| 07/04/2002 | CA2433520A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | CA2433100A1 Indole derivatives as ligands of thyroid receptors |
| 07/04/2002 | CA2432715A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | CA2432693A1 Identification of modulators of dham-kinase and inflammatory diseases |
| 07/04/2002 | CA2432543A1 Combination drugs |
| 07/04/2002 | CA2430691A1 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | CA2430610A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219619A1 Piperidine derivatives |
| 07/03/2002 | EP1219608A1 Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218407A1 Uses of kappa-conotoxin pviia |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218381A2 AMINO SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218375A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
| 07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/03/2002 | EP1218369A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/03/2002 | EP1218359A2 Piperazine compounds |
| 07/03/2002 | EP1218347A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| 07/03/2002 | EP1218346A1 Pyrazole derivatives |
| 07/03/2002 | EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids |
| 07/03/2002 | EP1218049A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 07/03/2002 | EP1218029A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP1218007A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/03/2002 | EP1218000A1 Anti-cancer nitro- and thia-fatty acids |
| 07/03/2002 | EP0820279B1 Metered dose inhaler for albuterol |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1357002A Compositions for treating inflammatory response |
| 07/03/2002 | CN1356995A Substituted benzimidazole |
| 07/03/2002 | CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 07/03/2002 | CN1356990A Bicyclic heterocycles, medicaments contg. these compounds, their use and methods for prodn. thereof |
| 07/03/2002 | CN1356986A Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical prepns. comprising them |
| 07/03/2002 | CN1356911A Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 07/03/2002 | CN1356902A IL-8 receptor antagonists |
| 07/03/2002 | CN1356897A Method of treating sleep apnoea |
| 07/03/2002 | CN1356323A Benzothiazolone derivative |
| 07/03/2002 | CN1356132A Chinese-medicinal bag tea for treating chronic pharyngitis and vocal fold disease and its preparing process |
| 07/03/2002 | CN1356127A Oral liquid for treating cough and asthma |
| 07/03/2002 | CN1356119A Antisussive syrup and its preparing process |
| 07/03/2002 | CN1356116A Buccal cordyceps lozenge |
| 07/03/2002 | CN1086951C Instant powder for common cold |
| 07/03/2002 | CN1086945C Diphtheria oral liquor |
| 07/03/2002 | CN1086940C Dinucleotides useful for treating lung disease |
| 07/02/2002 | US6414153 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414026 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 07/02/2002 | US6414025 Rheumatic disorders; antiinflammatory agents; autoimmune diseases |
| 07/02/2002 | US6413995 Immunomodulators |
| 07/02/2002 | US6413991 Antidiabetic agents; dietetics |
| 07/02/2002 | US6413979 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/02/2002 | US6413978 Basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
| 07/02/2002 | US6413977 Chromeno[4,3,2-DE]isoquinolines as potent dopamine receptor ligands |
| 07/02/2002 | US6413975 Purine derivatives having phosphodiesterase iv inhibition activity |
| 07/02/2002 | US6413969 Gatifloxacin pentahydrate |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413960 Substituted pyrazolyl benzenesulfonamides for the treatment of asthma |
| 07/02/2002 | US6413958 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-barr virus; enzyme inhibitors |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413547 Thermotropic; antibiotics; antiinflammatory agents; antihistamines |
| 07/02/2002 | CA2253080C 5-substituted picolinic acid compounds and their production process |
| 07/02/2002 | CA2047283C Pyrazolopyridine compound and processes for preparation thereof |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | WO2002050286A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |